207 related articles for article (PubMed ID: 2761491)
1. Chemical medullectomy does not prevent sodium retention in nephrotic rats.
Keeler R
Miner Electrolyte Metab; 1989; 15(4):241-5. PubMed ID: 2761491
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
[TBL] [Abstract][Full Text] [Related]
3. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.
Pedraza-Chaverrí J; Cruz C; Chávez MT; Ibarra-Rubio ME; Tapia E; Peña JC
Rev Invest Clin; 1990; 42(3):210-6. PubMed ID: 2270368
[TBL] [Abstract][Full Text] [Related]
5. Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleoside-induced nephrotic syndrome.
Audigé A; Yu ZR; Frey BM; Uehlinger DE; Frey FJ; Vogt B
Clin Sci (Lond); 2003 Apr; 104(4):389-95. PubMed ID: 12653683
[TBL] [Abstract][Full Text] [Related]
6. Role of uroguanylin, a Peptide with natriuretic activity, in rats with experimental nephrotic syndrome.
Kikuchi M; Fujimoto S; Fukae H; Kinoshita H; Kita T; Nakazato M; Eto T
J Am Soc Nephrol; 2005 Feb; 16(2):392-7. PubMed ID: 15590761
[TBL] [Abstract][Full Text] [Related]
7. Chemical renal medullectomy and experimental hypertension.
Russell GI; Bing RF; Taverner D; Swales JD; Thurston H
Proc Eur Dial Transplant Assoc; 1983; 20():546-50. PubMed ID: 6581483
[TBL] [Abstract][Full Text] [Related]
8. Effects of uroguanylin on natriuresis in experimental nephrotic rats.
Baba A; Fujimoto S; Kikuchi M; Kita T; Kitamura K
Nephrology (Carlton); 2009 Feb; 14(1):80-5. PubMed ID: 19054333
[TBL] [Abstract][Full Text] [Related]
9. Effects of low protein diet in puromycin aminonucleoside-induced nephrotic rats.
Shibasaki T; Gomi H; Ishimoto F; Sakai O
Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):871-5. PubMed ID: 2250404
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
Pedraza-Chaverrí J; Cruz C; Chávez MT; López A; Ibarra-Rubio ME; Tapia E; Peña JC
Rev Invest Clin; 1990; 42(2):120-6. PubMed ID: 2267444
[TBL] [Abstract][Full Text] [Related]
11. Hyperaldosteronemia and activation of the epithelial sodium channel are not required for sodium retention in puromycin-induced nephrosis.
Lourdel S; Loffing J; Favre G; Paulais M; Nissant A; Fakitsas P; Créminon C; Féraille E; Verrey F; Teulon J; Doucet A; Deschênes G
J Am Soc Nephrol; 2005 Dec; 16(12):3642-50. PubMed ID: 16267158
[TBL] [Abstract][Full Text] [Related]
12. Studies on the effectiveness of sairei-to on puromycin aminonucleoside nephrosis in rats.
Joarder ZH; Ogawa T; Yorioka N; Yamakido M
Hiroshima J Med Sci; 1991 Dec; 40(4):127-35. PubMed ID: 1797743
[TBL] [Abstract][Full Text] [Related]
13. Severe proteinuria without impairment of sodium and volume excretion after puromycin aminonucleoside administration in rats.
Palluk R; Veress AT; Sonnenberg H
Pharmacology; 1989; 38(4):214-25. PubMed ID: 2526952
[TBL] [Abstract][Full Text] [Related]
14. Increased expression but not targeting of ENaC in adrenalectomized rats with PAN-induced nephrotic syndrome.
de Seigneux S; Kim SW; Hemmingsen SC; Frøkiaer J; Nielsen S
Am J Physiol Renal Physiol; 2006 Jul; 291(1):F208-17. PubMed ID: 16403831
[TBL] [Abstract][Full Text] [Related]
15. Regulation of epithelial sodium channel in puromycin aminonucleoside-induced unilateral experimental nephrotic syndrome in normal and analbuminemic Nagase rats.
Yu Z; Schumacher M; Frey BM; Frey FJ; Vogt B
Nephron Physiol; 2005; 101(3):p51-62. PubMed ID: 16020936
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
[TBL] [Abstract][Full Text] [Related]
17. Fluid volumes and hemodynamics in hypertension produced by chemical renal medullectomy.
Taverner D; Bing RF; Swales JD; Thurston H
Am J Physiol; 1985 Aug; 249(2 Pt 2):H415-20. PubMed ID: 3895983
[TBL] [Abstract][Full Text] [Related]
18. Reduced renal medullary water channel expression in puromycin aminonucleoside--induced nephrotic syndrome.
Apostol E; Ecelbarger CA; Terris J; Bradford AD; Andrews P; Knepper MA
J Am Soc Nephrol; 1997 Jan; 8(1):15-24. PubMed ID: 9013444
[TBL] [Abstract][Full Text] [Related]
19. Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats.
Bistrup C; Thiesson HC; Jensen BL; Skøtt O
Acta Physiol Scand; 2005 Jun; 184(2):161-9. PubMed ID: 15916676
[TBL] [Abstract][Full Text] [Related]
20. Osmoregulation of natriuretic peptide receptors in bromoethylamine-treated rat kidney.
Yuan K; Jin X; Gao S; Shah A; Kim SY; Kim SZ; Kim SH
Peptides; 2009 Jun; 30(6):1137-43. PubMed ID: 19463747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]